GR 103691
CAS 162408-66-4 MFCD00936840
化学结构图
SMILES: CC(=O)C1C=CC(=CC=1)C1C=CC(=CC=1)C(=O)NCCCCN1CCN(CC1)C1=CC=CC=C1OC
化学属性
| Mol. Formula | C30H35N3O3 |
|---|---|
| Mol. Weight | 485.62 |
别名和识别编码
| Chemical Name | GR 103691 |
|---|---|
| Synonym | 4'-Acetyl-N-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]-[1,1'-biphenyl]-4-carboxamide GR 103691 |
| MDL Number | MFCD00936840 |
| PubChem Substance ID | 24724488 |
| CAS Number | 162408-66-4 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} Antagonists, Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, Dopaminargics - Antagonists, Dopaminergics, G, GPCR Modulators, GPCR Proteins, Modulators and Antibodies, GlaxoSmithKline, Membrane Protein Biology Tools, Neuroscience, Neurotransmission, Neurotransmitters, 生化试剂, 生物活性小分子, 细胞信号转导和神经科学, 细胞生物学, 蛋白质及衍生物
- {SNA} Antagonists, Approved Therapeutics/Drug Candidates, Bioactive Small Molecules, Biochemicals and Reagents, Cell Biology, Cell Signaling and Neuroscience,
相关文献及参考
- [1]. Audinot V, et al. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194. J Pharmacol Exp Ther. 1998 Oct;287(1):187-97.
京ICP备2020036287号